NVCN Neovasc Inc.

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Tiara and the Neovasc Reducer.

Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol CT:NVCN.

$0.77
As of 05/12/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  Canada
Country of incorporation:  
IPO date:  02/27/2013
Outstanding shares:  67,504,063
Average volume:  1,297,243
Market cap:   $54,604,037
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    64065J106
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   -1.93
PB ratio:   0.62
PS ratio:   27.90
Return on equity:   -1,451.06%
Net income %:   -1,466.01%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy